Hemovigilance

An Effective Tool for Improving Transfusion Safety

Inbunden, Engelska, 2012

Av René R. P. De Vries, Jean-Claude Faber, Rene R. P. De Vries, René R. P. de Vries, René R P de Vries

2 189 kr

Beställningsvara. Skickas inom 5-8 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

* Hemovigilance is a "quality process" which aims to improve quality and increase safety of blood transfusion, by surveying all activities of the blood transfusion chain, from donors to recipients.Hemovigilance programmes have now been in existence for over 15 years, but many countries and centers are still at the development stage. This valuable resource brings together the main elements of such programmes and shows the different types of models available. A general introduction includes Chapters on hemovigilance as a quality tool for transfusion as well as concepts of and models for hemovigilance. The core of the book describes how Hemovigilance systems have been set up and how they work in hospitals, blood establishments, and at a national level. These Chapters are written according to a structured template: products and processes, documentation of jobs, monitoring and assessment, implementation and evaluation of measures for improvement, education and training. Chapters on Hemovigilance at the International level, Achievements and new developments complete the picture.Hemovigilance is above all a practical guide to setting up and improving hemovigilance systems, whilst raising awareness for reporting adverse events and reactions.This is the first international book on hemovigilance, assembling all the vital issues in one definitive reference source - essential reading for all staff involved in the transfusion process.

Produktinformation

Utgivningsdatum2012-08-31
Mått193 x 254 x 23 mm
Vikt1 002 g
FormatInbunden
SpråkEngelska
Antal sidor392
FörlagJohn Wiley and Sons Ltd
ISBN9780470655276

Tillhör följande kategorier

Hematologi inom Medicin
Farmakologi inom Medicin

Professor René R.P. De Vries, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands and President of the European Haemovigilance Network. Dr Jean Claude Faber, Director of the Blood Transfusion Service, Luxembourg Red Cross, Luxembourg.The editors are experts in the field of haemovigilance. Both are members of the Board of the International Haemovigilance Network (IHN) and of the International Society of Blood Transfusion (ISBT) Working Party on Haemovigilance.

List of Contributors, viii Foreword, xiiPart 1 General Introduction1 Introduction, 3Ren´e R.P. de Vries2 Hemovigilance: A Quality Tool for the Blood Transfusion Chain, 5Ren´e R.P. de Vries3 Concepts and Models, 12Ren´e R.P. de Vries and Jean-Claude FaberPart 2 Hemovigilance of the Blood Transfusion Chain (Blood Establishment and Hospital)Section 2.1: Setting up a Hemovigilance System4 Setting Up or Consolidating a System for Donor Hemovigilance at the Level of a Blood Establishment, 21Johanna Wiersum-Osselton, Wim de Kort, Tanneke Marijt-van der Kreek, and Jeroen de Wit5 Preparation of Blood Components, 36Tomislav Vuk6 Establishment of Hemovigilance for the Testing, Storage, Distribution, Transport, and Issuing of Blood and Blood Components: The Example of Greece, 52Constantina Politis7 Medical Decision, Ordering, Administration of Component, and Monitoring of the Patient, 61Mickey B.C. Koh, Ramir Alcantara, Mark Grumbridge, and Ai Leen AngSection 2.2: How the System Works8 Blood Donation: An Approach to Donor Vigilance, 77Peter Tomasulo, Madhav Erraguntla, and Hany Kamel9 Preparation of Blood Components, 99Erhard Seifried, Reinhard Henschler, Juergen Luhm, Thea Mueller-Kuller, Hans-Ulrich Pfeiffer, Walid Sireis, and Markus M. Mueller10 Testing, Issuing, and Transport of Blood Components, 113Constantina Politis11 Clinical Activities: Medical Decision-making, Sampling, Ordering Components, Administration, and Patient Monitoring, 126Clare TaylorPart 3 National or Regional Hemovigilance Systems12 The French Hemovigilance Network: From the Blood Scandal to Epidemiologic Surveillance of the Transfusion Chain, 147Philippe Renaudier13 The Japanese Hemovigilance System, 159Hitoshi Okazaki, Naoko Goto, Shun-ya Momose, Satoru Hino, and Kenji Tadokoro14 Setting up a National Hemovigilance System: SHOT, 168Hannah Cohen and Lorna M. Williamson15 The Dutch Hemovigilance System: Transfusion Reactions in Patients (TRIP), 180Martin R. Schipperus, Johanna Wiersum-Osselton, Pauline Y. Zijlker-Jansen, and Anita J.W. van Tilborgh-de Jong16 Regulatory, Public Health, and International Aspects of Hemovigilance in Canada, 191Peter R. Ganz and Jun Wu17 Setting up and Implementation of the National Hemovigilance System in Italy, 204Giuliano Grazzini and Simonetta Pupella18 The Australian Hemovigilance System, 209Erica M. Wood, Lisa J. Stevenson, Simon A. Brown, and Christopher J. Hogan19 Biovigilance in the United States, 220D. Michael Strong, Barbee Whitaker, Matthew J. Kuehnert, and Jerry A. Holmberg20 Arab Hemovigilance Network, 226Salwa Hindawi, Magdy Elekiaby, and Gamal GabraPart 4 Hemovigilance at the International Level21 Hemovigilance in the European Community, 235Jean-Claude Faber22 International collaboration, 253Paul F.W. Strengers23 Hemovigilance in Developing Countries, 260Jean-Claude FaberPart 5 Achievements24 Achievements Through Hemovigilance, 281Jean-Claude Faber and F´atima NascimentoPart 6 Developments25 Vigilance of Alternatives for Blood Components, 305Dafydd Thomas26 Surveillance of Clinical Effectiveness of Transfusion, 322Brian McClelland and Katherine Forrester27 Biovigilance, 326Jerry A. Holmberg, Matthew J. Kuehnert, and D. Michael StrongAppendicesAppendix A Glossary, 343Appendix B Proposed standard definitions for surveillance of non infectious adverse transfusion reactions, 351Appendix C Standard for surveillance of complications related to blood donation, 360Index, 369